Product Introduction
Chronic hepatitis B is a serious liver infection caused by the hepatitis B virus (HBV). Durataf (Tenofovir Alafenamide 25mg) offers a reliable solution for managing this condition. It works by targeting and inhibiting the replication of the virus, thus helping to reduce viral load and prevent liver damage.
Designed with patient safety in mind, Durataf is known for its reduced impact on kidney function and bone density compared to older antiviral therapies. Its once-daily oral administration ensures convenience and adherence, enabling better health outcomes for those living with chronic hepatitis B.
Uses of Durataf (Tenofovir Alafenamide 25mg)
Durataf is primarily indicated for:
- Chronic Hepatitis B – Reduces viral replication and liver damage in adults with active HBV infection.
- Hepatitis B Virus Prophylaxis – Offers protection against HBV reactivation in high-risk patients.
Side Effects of Durataf (Tenofovir Alafenamide 25mg)
Common side effects may include:
- Nausea
- Fatigue
- Headache
- Abdominal pain